Does Maribavir Interact with Rifabutin?
CDI records a moderate classification for Maribavir and Rifabutin. The stored summary is: Moderate CYP3A4 inducer that decreases maribavir concentrations. A dose adjustment of LIVTENCITY is recommended when coadministered. The mechanism involves cyp3a4 induction. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Maribavir Class
- Cytomegalovirus pUL97 Kinase Inhibitor
- Rifabutin Class
- Rifamycin Antimycobacterial
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
CYP3A4 induction
What To Tell Your Doctor or Pharmacist
If you are taking Maribavir and your doctor is considering prescribing Rifabutin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider